Developer docs
API playgroundTry for free, no card

Search company profiles

K2M

Full company profile

uuid0039xt9

Namestring
K2M
Legal namestring
Stryker Corporation
Websiteurl
k2m.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

K2M is a medical device company specializing in the design, development, and commercialization of spine surgery technologies. Founded in 2004 and headquartered in the United States, K2M built a portfolio of spinal implant systems, surgical instruments, and complex spine solutions targeting hospitals, health systems, ambulatory surgery centers, and spine and neurosurgical specialists. The company went public on NASDAQ under ticker KTWO in 2013 and raised a $40 million financing round in January 2015 to support product platform expansion.

Post-2018, K2M operates as a wholly-owned subsidiary of Stryker Corporation within its Neurosurgical and Spine division, with division headquarters in Portage, Michigan. The combined franchise sells spinal implants, surgical navigation systems, and enabling-technology software platforms including the Balance ACS (BACS) perioperative workflow platform and the Q Guidance spinal and cranial navigation system. Revenue is generated primarily through direct enterprise field sales to healthcare institutions under quote-based B2B contracts, with a growing component of recurring software and services tied to enabling-technology platforms. The franchise is identified as one of seven leading global spinal surgery device players alongside Medtronic, DePuy Synthes, Zimmer Biomet, Globus Medical, and NuVasive.

Short descriptiontext

K2M, now operating as Stryker's Spine division following its 2018 acquisition, designs and commercializes spinal implants, surgical navigation systems, and enabling-technology software platforms such as Balance ACS and Q Guidance for hospitals, ambulatory surgery centers, and spine and neurosurgeons.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersLeesburg, United States
HQ citystring
Leesburg
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
spinal implants, spine surgery devices, surgical navigation systems, complex spine solutions, medical device manufacturer
Product category
Spinal Implants and Surgical Navigation Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Spinal Implants and Devices
TypeHardware Sales
Description

Sale of spinal implant systems, surgical instruments, and related medical devices to hospitals and surgical centers. Revenue is generated through direct sales transactions with healthcare institutions, typically involving competitive bidding and contract negotiations.

stryker.com
2Surgical Navigation Systems
TypeHardware Sales
Description

Sale and service of navigation systems including Q Guidance and related software platforms. May include installation, training, and ongoing support services bundled with hardware.

stryker.com
3Enabling Technology Platforms
TypeSubscription Recurring
Description

Software and technology platforms like Balance ACS that support surgical workflows. May include subscription or licensing components for software updates and cloud-based services.

stryker.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Supply Chain, Marketing or Sales, Technology or R&D, Operations
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

K2M develops, manufactures, and markets spinal implant systems and surgical navigation technology used in spine surgery procedures. Its principal offerings are the Balance ACS (BACS) implant platform and the Q Guidance surgical navigation system. Following its 2018 acquisition by Stryker, K2M operates as Stryker's Spine division, selling directly to hospitals, spine surgeons, and ambulatory surgery centers through a field sales force with dedicated U.S. and European coverage.

Differentiator
Functional benefit
Problem solved
Product and service2 records
1Balance ACS (BACS)
CategorySpinal Implants
2Q Guidance System
CategorySurgical Navigation Systems
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat4 records

Each record includes

Type, Details

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

K2M

Spinal Implants and Surgical Navigation Devicesk2m.com

K2M, now operating as Stryker's Spine division following its 2018 acquisition, designs and commercializes spinal implants, surgical navigation systems, and enabling-technology software platforms such as Balance ACS and Q Guidance for hospitals, ambulatory surgery centers, and spine and neurosurgeons.

What K2M does

K2M is a medical device company specializing in the design, development, and commercialization of spine surgery technologies. Founded in 2004 and headquartered in the United States, K2M built a portfolio of spinal implant systems, surgical instruments, and complex spine solutions targeting hospitals, health systems, ambulatory surgery centers, and spine and neurosurgical specialists. The company went public on NASDAQ under ticker KTWO in 2013 and raised a $40 million financing round in January 2015 to support product platform expansion.

Post-2018, K2M operates as a wholly-owned subsidiary of Stryker Corporation within its Neurosurgical and Spine division, with division headquarters in Portage, Michigan. The combined franchise sells spinal implants, surgical navigation systems, and enabling-technology software platforms including the Balance ACS (BACS) perioperative workflow platform and the Q Guidance spinal and cranial navigation system. Revenue is generated primarily through direct enterprise field sales to healthcare institutions under quote-based B2B contracts, with a growing component of recurring software and services tied to enabling-technology platforms. The franchise is identified as one of seven leading global spinal surgery device players alongside Medtronic, DePuy Synthes, Zimmer Biomet, Globus Medical, and NuVasive.

K2M firmographics

Firmographics
Name
K2M
Legal name
Stryker Corporation
Website
https://k2m.com
Company type
Private
Founded year
2004
Operating status
Acquired
Headcount range
251–500 employees
Short description
K2M, now operating as Stryker's Spine division following its 2018 acquisition, designs and commercializes spinal implants, surgical navigation systems, and enabling-technology software platforms such as Balance ACS and Q Guidance for hospitals, ambulatory surgery centers, and spine and neurosurgeons.
Ownership category
akta.pro rank

Where K2M is headquartered

Location

Headquarters

HQ city
Leesburg
HQ country
United States
HQ region
North America

Offices1 record

Markets served

K2M business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Supply Chain, Marketing or Sales, Technology or R&D, Operations

Revenue model

  1. Spinal Implants and Devices: Sale of spinal implant systems, surgical instruments, and related medical devices to hospitals and surgical centers. Revenue is generated through direct sales transactions with healthcare institutions, typically involving competitive bidding and contract negotiations.
  2. Surgical Navigation Systems: Sale and service of navigation systems including Q Guidance and related software platforms. May include installation, training, and ongoing support services bundled with hardware.
  3. Enabling Technology Platforms: Software and technology platforms like Balance ACS that support surgical workflows. May include subscription or licensing components for software updates and cloud-based services.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

K2M product offering

Product offering

Core offering

K2M develops, manufactures, and markets spinal implant systems and surgical navigation technology used in spine surgery procedures. Its principal offerings are the Balance ACS (BACS) implant platform and the Q Guidance surgical navigation system. Following its 2018 acquisition by Stryker, K2M operates as Stryker's Spine division, selling directly to hospitals, spine surgeons, and ambulatory surgery centers through a field sales force with dedicated U.S. and European coverage.

Differentiator

Problem solved

Functional benefit

Products and services

  • Balance ACS (BACS)
  • Q Guidance System

Companies that use K2M

Customer profile

Segments3 records

Ideal customer profiles1 record

K2M technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

K2M partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

K2M competitors and assessment

Company assessment

Market position

Competitive moat4 records

Customer concentration

K2M social profiles

Digital presence

K2M financial estimates

Financial estimate

Revenue estimate

Valuation estimate

K2M leadership team

Management profile

Number of profiles

Profiles5 records

K2M subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

K2M funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

K2M M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about K2M

What does K2M do?

K2M develops, manufactures, and markets spinal implant systems and surgical navigation technology used in spine surgery procedures. Its principal offerings are the Balance ACS (BACS) implant platform and the Q Guidance surgical navigation system. Following its 2018 acquisition by Stryker, K2M operates as Stryker's Spine division, selling directly to hospitals, spine surgeons, and ambulatory surgery centers through a field sales force with dedicated U.S. and European coverage.

Is K2M a public or private company?

K2M is a private company. It is classified as corporate owned and is currently acquired.

When was K2M founded?

K2M was founded in 2004. It employs 251 to 500 people.

Where is K2M based?

K2M is headquartered in Leesburg, United States, in the North America region.

How does K2M make money?

Three revenue lines are on record. Spinal Implants and Devices are the primary driver. The others are surgical Navigation Systems and enabling Technology Platforms.

Does K2M have an API?

No public API is recorded for K2M.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioSpaceProvidence™ Medical Technology Appoints Lane Major as President & Chief Executive OfficerProvidence Medical Technology appointed Lane Major as President & CEO, joining its Board. Major brings over 25 years of spine industry experience, including roles at Zavation and Stryker. The appointment follows growth in adoption of its CORUS tissue-sparing fusion technology.American City Business JournalsFormer K2M exec Lane Major takes helm of GrenovaLane Major was named president and CEO of Grenova, taking over from founder Ali Safavi. The move follows Peloton Equity's majority stake purchase a year prior. Major aims to expand Grenova's product line and international presence, building on K2M's growth.GlobeNewswireK2M Group Holdings, Inc. Announces Fundamental Change With Respect to its 3.00% Convertible Senior Notes due 2025 and 4.125% Convertible Senior Notes due 2036K2M Group Holdings announced a fundamental change under its indentures for 3.00% and 4.125% convertible senior notes due 2025 and 2036, effective November 9, 2018. Holders of the 2036 notes can require repurchase at $1,013.52 per $1,000 on December 13, 2018, while 2025 note holders have no repurchase right. Conversion rates for both notes were increased.GlobeNewswireK2M Group Holdings, Inc. Stockholders Approve Acquisition by StrykerK2M Group Holdings stockholders approved the merger agreement with Stryker, making K2M a wholly-owned subsidiary of Stryker. The merger consideration is $27.50 per share in cash, with closing expected in the fourth quarter of 2018.GlobeNewswireK2M Group Holdings, Inc. Announces Record Date and Meeting Date for Special Meeting of StockholdersK2M Group Holdings set a record date of October 4, 2018 and a special meeting date of November 7, 2018 for stockholders to vote on a merger with Stryker. The merger would pay $27.50 per share in cash, with closing expected in the fourth quarter of 2018.WsjStryker Agrees to Buy Spinal-Device Maker K2MStryker Corp. agreed to acquire K2M Group Holdings in a deal valued at about $1.4 billion. The purchase price of $27.50 per share represents a 27% premium over K2M's average three-month closing price. K2M will be incorporated into Stryker's spine division, broadening its spinal therapy portfolio.GlobeNewswireK2M Group Holdings, Inc. Announces Definitive Agreement To Be Acquired by Stryker CorporationStryker agreed to acquire K2M Group Holdings in an all-cash deal for $27.50 per share, a 27% premium, valuing the company at about $1.4 billion. The transaction is expected to close in late 2018, with K2M's CEO to become Stryker's spine division president.Medical Device and Diagnostic industryStryker to Pick up K2M for $1.4BStryker announced it is acquiring K2M, a specialist in complex spine and minimally invasive surgery, for $1.4 billion in an all-cash transaction. The deal values K2M at $27.50 per share, representing a 27% premium over the company's average closing price during the prior 90 trading days, and is expected to close in late Q4 2018. The acquisition is intended to boost Stryker's spinal division, with K2M's CEO Eric Major expected to stay on as president of Stryker's spine business.GlobeNewswireK2M Group Holdings, Inc. to Participate in Two Investor Conferences in SeptemberK2M Group Holdings announced management will participate in two investor conferences in September: a Wells Fargo conference on September 6 and a Morgan Stanley conference on September 13. Live webcasts will be provided, with archives available for replay.GlobeNewswireK2M Group Holdings, Inc. Reports Second Quarter 2018 Financial Results and Updates Fiscal Year 2018 OutlookK2M Group reported Q2 2018 revenue of $73.6 million, up 12% year-over-year, with a net loss of $10.8 million. The company raised its FY2018 revenue guidance to $288–291 million, up 12–13% from the prior year's $258 million.